Difference between revisions of "Zoledronic acid (Zometa)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "or the prescribing information<ref name="insert"></ref>." to "or the prescribing information.<ref name="insert"></ref>")
(updated references)
Line 1: Line 1:
 +
Also known as Aclasta, Reclast, zoledronate, or Zomera.
 +
 
==General information==
 
==General information==
Class: Bisphosphonate, inhibits osteoclast activity and bone resorption/turnover, induces osteoclast apoptosis<ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/Zometa.pdf Zoledronic acid (Zometa) package insert]</ref><ref>[http://hemonc.org/docs/chemotherapypackageinsert/zoledronicacid.pdf Zoledronic acid (Zometa) package insert (locally hosted backup)]</ref><ref>[http://www.zometa.com Zometa manufacturer's site]</ref>
+
Class: Bisphosphonate, inhibits osteoclast activity and bone resorption/turnover, induces osteoclast apoptosis, and inhibits skeletal calcium release by tumor stimulatory factors.<ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/Zometa.pdf Zoledronic acid (Zometa) package insert]</ref><ref>[[Media:zoledronicacid.pdf | Zoledronic acid (Zometa) package insert (locally hosted backup)]]</ref><ref>[http://www.zometa.com Zometa manufacturer's site]</ref>
 
<br>Route: IV
 
<br>Route: IV
 
<br>Extravasation: no information
 
<br>Extravasation: no information
Line 7: Line 9:
  
 
==Patient drug information==
 
==Patient drug information==
 +
*[http://chemocare.com/bio/zoledronic_acid.asp Zoledronic acid (Zometa) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/zoledronic_acid.asp Zoledronic acid (Zometa) patient drug information (Chemocare)]</ref>
 +
*Brief patient counseling information can be found on pages 21-22 of the [http://www.pharma.us.novartis.com/product/pi/pdf/Zometa.pdf#page=21 Zoledronic acid (Zometa) package insert]<ref name="insert"></ref>
 
*[http://www.uptodate.com/contents/zoledronic-acid-patient-drug-information Zoledronic acid (Zometa) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/zoledronic-acid-patient-drug-information Zoledronic acid (Zometa) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/zoledronic-acid-patient-drug-information Zoledronic acid (Zometa) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/zoledronic-acid-patient-drug-information Zoledronic acid (Zometa) patient drug information (UpToDate)]</ref>
  
 
==References==
 
==References==
 
<references/>
 
<references/>

Revision as of 16:40, 12 September 2012

Also known as Aclasta, Reclast, zoledronate, or Zomera.

General information

Class: Bisphosphonate, inhibits osteoclast activity and bone resorption/turnover, induces osteoclast apoptosis, and inhibits skeletal calcium release by tumor stimulatory factors.[1][2][3]
Route: IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

References